Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.26 CAD Market Closed
Market Cap: 63.1m CAD
Have any thoughts about
Theralase Technologies Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-14.4
Current
-12.1
Median
12.8
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-14.4
=
Enterprise Value
59.6m CAD
/
EBITDA
-4.2m CAD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More